首页|Complete blood and urine paraprotein tests as response assessments in multiple myeloma patients treated with bortezomib, cyclophosphamide, and dexamethasone

Complete blood and urine paraprotein tests as response assessments in multiple myeloma patients treated with bortezomib, cyclophosphamide, and dexamethasone

扫码查看

bortezomiblight chain subtypemultiple myelomaresponse assessment

Lan Xialu、Zhang Fujing、Yang Chen、Su Wei、Du Jianhua、Liu Shuangjiao、Chen Miao、Han Bing、Zhou Daobin、Zhuang Junling

展开 >

Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China

2Department of Pathology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China

Department of Laboratory Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China

bortezomib light chain subtype multiple myeloma response assessment

National High Level Hospital Clinical Research FundingCapital Health Development Scientific Research Fund

2022-PUMCH-B-0482022-2-4013

2024

慢性疾病与转化医学(英文)

慢性疾病与转化医学(英文)

CSTPCD
ISSN:2095-882X
年,卷(期):2024.10(1)
  • 17